US Onychomycosis Market is expected grow USD 5.7 Billion at a CAGR 8.90% during the forecast 2022 - 2030
Onychomycosis is a contagious disease of the nails that causes staining, thickening, and partition from the nail bed. Onychomycosis happens in 10% of the all-inclusive population, 20% of people older than 60 years, and half of those older than 70 years. It is brought about by an assortment of organisms, however most cases are brought on by dermatophytes. The US market for Onychomycosis is expected to reach high market figures by the end of the forecasted period and is expected to grow at a CAGR of 6.4%
US Onychomycosis market has been segmented on the basis of types which comprises of distal subungual onychomycosis (dso), white superficial onychomycosis (WSO), proximal subungual onychomycosis (PSO), endonyx onychomycosis (EO), and others.
The US market for Onychomycosis is expected to grow at a CAGR of 6.4% and is expected to reach at more than US$ 5 billion by the end of the forecasted period. This is due to increasing ageing populations.
Key Players for Onychomycosis Market:
Some of the key players in this market are: Anacor Pharmaceuticals, Johnson and Johnson, Novartis, Valeant Pharmaceuticals
The report for US Onychomycosis market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions
|Market Size||USD 5 Billion|
|Forecast Units||Value (USD Million)|
|Report Coverage||Revenue Forecast, Competitive Landscape, Growth Factors, and Trends|
|Geographies Covered||U.S. and Canada|
|Key Vendors||Anacor Pharmaceuticals, Johnson and Johnson, Novartis, Valeant Pharmaceuticals|
|Key Market Opportunities||Joint ventures, strategic alliances, mergers and acquisitions, new product developments along with research and developments|
|Key Market Drivers||technological advancement, macro economical and governing factors|